Treace Medical Concepts, Inc. TMCI 深 沪
等待开盘 11-06 09:30:00 美东时间
4.18
-0.320
-7.11%
华盛通- 最 高4.50
- 今 开4.48
- 成交量 32.33万股
- 最 低 3.96
- 昨 收 4.50
- 总市值 2.72亿
- 52周最高 5.25
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.17
- 委 比 -43.18%
- 总股本 6503.46万
- 历史最高 37.17
- 量 比 1.23
- 振 幅 12.00%
- 历史最低 1.17
- 每 手 1
- 风险率 1.19%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Treace Medical Concepts Narrows FY2026 Sales Guidance from $204.000M-$212.000M to $206.000M-$210.000M vs $207.488M Est
Treace Medical Concepts (NASDAQ:TMCI) narrows FY2026 sales outlook from $204.000 million-$212.000 million to $206.000 million-$210.000 million vs $207.488 million estimate.
今天 20:05
Treace Announces First Surgical Cases with the Tailorplasty™ MIS Tailor’s Bunion Correction System
Treace Medical Concepts announced the successful launch of its Tailorplasty™ MIS Tailor’s Bunion Correction System, addressing fifth metatarsal deformities, or tailor’s bunions, affecting 5-10% of adults. The system offers a minimally invasive solution with instrument-guided correction and a unique fixation implant, improving surgical accuracy and stability. Designed to simplify challenging procedures, Tailorplasty™ aims to expand Treace’s market...
今天 12:04
Treace to Present at the Stifel 2026 Healthcare Conference
Treace Medical Concepts, a medical technology company specializing in bunion and foot/ankle condition treatments, announced its participation in the Stifel 2026 Healthcare Conference on November 11, 2026, at 1:20 pm ET. The event will feature a fireside chat available via live webcast and replay on the company’s investor relations website. Treace, known for its innovative surgical systems like the Lapiplasty 3D Bunion Correction System, aims to b...
11-03 21:05
Treace Medical Concepts收跌3.61%，成交额75.24万美元
11月3日，Treace Medical Concepts（TMCI）收跌3.61%，报4.27美元，成交额75.24万美元，市值2.78亿美元。 行情数据 ...
11-03 07:27
Treace Medical Concepts收涨3.51%，成交额68.79万美元
10月27日，Treace Medical Concepts（TMCI）收涨3.51%，报4.42美元，成交额68.79万美元，市值2.87亿美元。 行情数据...
10-27 06:28
Treace to Report Third Quarter 2026 Financial Results on November 6, 2026
Treace Medical Concepts, Inc. announced it will release its third-quarter 2026 financial results on November 6, 2026, followed by a conference call at 8:00 am ET. The company, focused on advancing bunion and midfoot deformity surgery, invites investors to register for the call and access a webcast on its investor relations website. Additional information is available on the company's website and social media platforms.
10-23 11:05
Treace Medical Concepts收跌6.07%，成交额52.05万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 06:36
Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting
Treace Medical Concepts will showcase new foot and ankle products and present clinical data at the 2026 AOFAS Annual Meeting. Key innovations include advancements in 3D bunion correction, minimally invasive solutions, and technologies for mid and hindfoot markets. The company aims to expand its leadership in bunion treatments while addressing broader foot and ankle needs. Clinical studies highlighting long-term outcomes of its technologies will a...
09-15 21:06
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
Treace Medical Concepts shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.
Treace Medical Concepts shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.
08-07 20:45
